# Nuvectis Pharma, Inc.: Form 8-K, filed Aug 5, 2025

- Company: [Nuvectis Pharma, Inc.](/companies/nvct.md) (CIK 1875558)
- Form: 8-K
- Filed: 2025-08-05
- Accepted by EDGAR: Aug 5, 2025, 08:39 ET
- Period: 2025-08-05
- Accession: 0001104659-25-073967
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1875558/000110465925073967/tm2522415d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1875558/000110465925073967/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1875558/000110465925073967/tm2522415d1_8k.htm

Filed Aug 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-073967. Last ingested by Listed: Nov 4, 2026, 08:08 ET. No prices; not investment advice.